{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:29:42Z","timestamp":1792654182496,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,22]],"date-time":"2018-07-22T00:00:00Z","timestamp":1532217600000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI77767"],"award-info":[{"award-number":["AI77767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.antiviral.2017.06.015","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T07:01:58Z","timestamp":1498028518000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor"],"prefix":"10.1016","volume":"145","author":[{"given":"Han","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Soloveva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima","family":"Gharaibeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Retterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouzbeh","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norton P.","family":"Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.06.015_bib1","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1128\/JVI.76.13.6841-6844.2002","article-title":"C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans","volume":"76","author":"Alvarez","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2006.08.018","article-title":"Release of cellular proteases into the acidic extracellular milieu exacerbates Ebola virus-induced cell damage","volume":"358","author":"Barrientos","year":"2007","journal-title":"Virology"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2017.06.015_bib3","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiv223","article-title":"Novel small molecule entry inhibitors of ebola virus","volume":"212","author":"Basu","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.015_bib4","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/v4123647","article-title":"Endocytic pathways involved in filovirus entry: advances, implications and future directions","volume":"4","author":"Bhattacharyya","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2017.06.015_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.05708-11","article-title":"Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change","volume":"86","author":"Brecher","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.06.015_bib7","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.06.015_bib8","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.01337-15","article-title":"Inhibition of ebola and Marburg virus Entry by G Protein-coupled receptor antagonists","volume":"89","author":"Cheng","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"Cote","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.06.015_bib10","doi-asserted-by":"crossref","first-page":"41226","DOI":"10.1038\/srep41226","article-title":"Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2017.06.015_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.06.015_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.virol.2011.11.031","article-title":"Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression","volume":"424","author":"Gnirss","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.06.015_bib13","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.cell.2016.05.022","article-title":"Structural insights into the niemann-pick C1 (NPC1)-Mediated cholesterol transfer and ebola infection","volume":"165","author":"Gong","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2017.06.015_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2005.06.026","article-title":"LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus","volume":"340","author":"Gramberg","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.06.015_bib15","doi-asserted-by":"crossref","first-page":"290ra289","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A\u00a0screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"Johansen","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2017.06.015_bib16","doi-asserted-by":"crossref","first-page":"13378","DOI":"10.1128\/JVI.01170-07","article-title":"Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity","volume":"81","author":"Kaletsky","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib17","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-010-0814-x","article-title":"Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations","volume":"155","author":"Kuhn","year":"2010","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib19","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/JVI.79.8.4793-4805.2005","article-title":"Comprehensive analysis of ebola virus GP1 in viral entry","volume":"79","author":"Manicassamy","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib20","doi-asserted-by":"crossref","first-page":"e1923","DOI":"10.1371\/journal.pntd.0001923","article-title":"Cathepsin B & L are not required for ebola virus replication","volume":"6","author":"Marzi","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2017.06.015_bib21","doi-asserted-by":"crossref","first-page":"e1001121","DOI":"10.1371\/journal.ppat.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2017.06.015_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/id500025n","article-title":"Chemical and structural aspects of ebola virus entry inhibitors","volume":"1","author":"Nyakatura","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.015_bib23","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/JVI.03689-14","article-title":"Role of EXT1 and glycosaminoglycans in the early stage of filovirus entry","volume":"89","author":"O'Hearn","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40588-015-0021-3","article-title":"Ebola virus entry into host cells: identifying therapeutic strategies","volume":"2","author":"Rhein","year":"2015","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"10.1016\/j.antiviral.2017.06.015_bib25","doi-asserted-by":"crossref","first-page":"e1001110","DOI":"10.1371\/journal.ppat.1001110","article-title":"Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes","volume":"6","author":"Saeed","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2017.06.015_bib26","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/JVI.01621-12","article-title":"Filoviruses utilize glycosaminoglycans for their attachment to target cells","volume":"87","author":"Salvador","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib27","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/mol.110.064261","article-title":"A\u00a0small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells","volume":"78","author":"Shah","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib29","doi-asserted-by":"crossref","first-page":"e56265","DOI":"10.1371\/journal.pone.0056265","article-title":"Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection","volume":"8","author":"Shoemaker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.06.015_bib30","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1055\/s-0028-1106144","article-title":"On the etiology of an unknown human infection originating from monkeys","volume":"92","author":"Siegert","year":"1967","journal-title":"Dtsch. Med. Wochenschr"},{"key":"10.1016\/j.antiviral.2017.06.015_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrd3859","article-title":"The GPCR Network: a large-scale collaboration to determine human GPCR structure and function","volume":"12","author":"Stevens","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2017.06.015_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2016.11.017","article-title":"Synergistic drug combination effectively blocks Ebola virus infection","volume":"137","author":"Sun","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.06.015_bib33","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/JVI.78.6.2943-2947.2004","article-title":"Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry","volume":"78","author":"Takada","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.015_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/acsinfecdis.5b00130","article-title":"Cysteine cathepsin inhibitors as anti-ebola agents","volume":"2","author":"van der Linden","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.015_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","article-title":"Ebola viral glycoprotein bound to its endosomal receptor niemann-pick C1","volume":"164","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2017.06.015_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1087057113494405","article-title":"A\u00a0comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses","volume":"19","author":"Wang","year":"2014","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.antiviral.2017.06.015_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene interacts with and destabilizes the Ebola virus glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.06.015_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421730356X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421730356X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:34Z","timestamp":1759062394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421730356X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":38,"alternative-id":["S016635421730356X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.015","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}